Invention Grant
- Patent Title: Enhanced treatment regimens using mTor inhibitors
- Patent Title (中): 使用mTor抑制剂增强治疗方案
-
Application No.: US14360267Application Date: 2012-11-21
-
Publication No.: US09174994B2Publication Date: 2015-11-03
- Inventor: Yi Liu , Lynne Bui , Michael Martin , Troy Edward Wilson , Christian Rommel
- Applicant: INTELLIKINE LLC
- Applicant Address: US CA La Jolla
- Assignee: Intellikine, LLC
- Current Assignee: Intellikine, LLC
- Current Assignee Address: US CA La Jolla
- Agency: Honigman Miller Schwartz and Cohn LLP
- Agent Lucy X. Yang; Jonathan P. O'Brien
- International Application: PCT/US2012/066431 WO 20121121
- International Announcement: WO2013/078440 WO 20130530
- Main IPC: A61K31/535
- IPC: A61K31/535 ; A61K31/4965 ; C07D487/04 ; C07D519/00 ; A61K31/519 ; A61K31/5377
Abstract:
The present invention provides for methods and pharmaceutical compositions comprising inhibitors of mTorC1 and/or mTorC2. In some aspects, the invention provides for treatment regimens resulting in enhanced treatment efficacy and better tolerability.
Public/Granted literature
- US20140287031A1 ENHANCED TREATMENT REGIMENS USING MTOR INHIBITORS Public/Granted day:2014-09-25
Information query
